Supporters
Special Thanks to the Supporters of the AACR Annual Meeting 2023 Cure Level AstraZeneca Bristol Myers Squibb Daiichi Sankyo,...
Patricia M. LoRusso, DO, PhD (hc), Elected as American Association for Cancer Research President-Elect for 2023-2024
Five new members elected to the Board of Directors PHILADELPHIA – The members of the American Association for Cancer...
AACR Announces Recipients of its 2023 Scientific Achievement Awards, Lectureships, and Prizes
Awardees to be recognized at the AACR Annual Meeting 2023 in Orlando PHILADELPHIA – The American Association for Cancer...
AACR to Recognize Elizabeth M. Jaffee, MD, FAACR, with 2023 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will honor Elizabeth M. Jaffee, MD, Fellow of the AACR...
American Association for Cancer Research Inaugurates New Leadership at the AACR Annual Business Meeting of Members 2023
Philip D. Greenberg, MD, FAACR, Inaugurated as President PHILADELPHIA – The members of the American Association for Cancer Research...
AACR Announces Fellows of the AACR Academy Class of 2023 and New AACR Academy President
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the...
AACR Announces Recipients for 2023 Distinguished Public Service Awards
PHILADELPHIA – The American Association for Cancer Research (AACR) will present the 2023 AACR Distinguished Public Service Awards for...
Carl H. June, MD, FAACR, Honored with 2023 AACR Award for Lifetime Achievement in Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Carl H. June, MD, Fellow of the AACR...
Tak W. Mak, PhD, FAACR, Selected for 2023 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research
PHILADELPHIA – The Pezcoller Foundation–American Association for Cancer Research (AACR) International Award for Extraordinary Achievement in Cancer Research will...
AACR Announces Recipients of the 2023 AACR June L. Biedler Prize for Cancer Journalism
PHILADELPHIA – The American Association for Cancer Research (AACR) is pleased to announce the recipients of the 2023 AACR...
E. John Wherry, PhD, Recognized With the 2023 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology
PHILADELPHIA – The American Association for Cancer Research (AACR) will award E. John Wherry, PhD, with the 2023 AACR-Cancer...
Andrea Schietinger, PhD, to Present 2023 AACR-Irving Weinstein Foundation Distinguished Lecture
PHILADELPHIA — The American Association for Cancer Research (AACR) will award the 19th AACR-Irving Weinstein Foundation Distinguished Lectureship to...
Olivier Delattre, MD, PhD, Honored with 2023 AACR-St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Olivier Delattre, MD, PhD, with the 2023 AACR-St....
Nobel Laureate Carolyn R. Bertozzi, PhD, to Receive 2023 AACR Award for Outstanding Achievement in Chemistry in Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will honor Nobel Laureate Carolyn R. Bertozzi, PhD, with the...
Four New Institutions Join AACR Project GENIE® Consortium
PHILADELPHIA — To further its commitment to diversity, equity, and inclusion, the American Association for Cancer Research (AACR) has...
Colorectal Cancer Patients With African Ancestry Had Fewer Clinically Actionable Alterations Than White Patients
ORLANDO, Fla. – Genomic profiling of patients who were treated for colorectal cancer at a major U.S. cancer center...
First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers
ORLANDO, Fla. – The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated...
Durvalumab-based Treatment Before and After Surgery Improved Outcomes for Patients With Resectable Non-small Cell Lung Cancer
Patients treated with the durvalumab-based regimen before and after surgery in the AEGEAN trial had a 32% reduction in...
Adjuvant Treatment With Atezolizumab and Bevacizumab May Delay Recurrence After Surgical Resection in Patients With Liver Cancer
ORLANDO, Fla. – Adjuvant therapy with atezolizumab (Tecentriq) and bevacizumab (Avastin) increased recurrence-free survival of patients with hepatocellular carcinoma...
Adding a Personalized mRNA Cancer Vaccine to Immunotherapy May Prolong Recurrence-free Survival in Patients With High-risk Melanoma
Clinical benefit was independent of patients’ tumor mutational burden ORLANDO, Fla. – mRNA-4157/V940, a personalized mRNA-based cancer vaccine,...
Lung Cancer Incidence Rates Varied Significantly Among Florida’s Black and Hispanic Ethnic Subgroups
Disaggregating statistics revealed key differences in ethnic populations ORLANDO, Fla. – An analysis of lung cancer incidence rates showed...
Awareness of the Link Between HPV and Cervical Cancer Has Declined
Most people are also not aware that HPV can cause anal, oral, and penile cancers ORLANDO, Fla. – Americans...
New Bispecific Antibody Demonstrates Clinical Activity in Patients With Multiple Myeloma
REGN5459 had decreased binding affinity to T cells, resulting in an encouraging side effect profile and efficacy ORLANDO, Fla....
Brain Metastases in Patients with Kidney Cancer May Have Immune-suppressive Tumor Microenvironments
Researchers applied single-nucleus RNA sequencing and spatial transcriptomics to identify potential therapeutic targets in brain metastases ORLANDO, Fla. –...
A Liquid Biopsy-based Multicancer Early Detection Test May Detect Early-stage Disease and Low DNA-shedding Cancers
The multicancer early detection platform was developed based on methylation of cell-free DNA ORLANDO, Fla. – A liquid biopsy-based...
Olaparib Plus Ceralasertib May Benefit Pediatric Cancer Patients With DNA Repair-deficient Tumors
ORLANDO, Fla. – A combination of the PARP inhibitor olaparib (Lynparza) and the investigational ATR inhibitor ceralasertib showed clinical...
Single-agent Pembrolizumab May Benefit Patients with Rare Type of Skin Cancer
ORLANDO, Fla. – Monotherapy with pembrolizumab (Keytruda) led to clinical responses in 89% of patients with unresectable metastatic desmoplastic...
An Investigational Deep Learning Model May Help Stratify Risk for Patients with Endometrial Cancer
ORLANDO, Fla. – An investigational deep learning model requiring one histopathologic slide accurately predicted the risk of distant recurrence...
Exome Sequencing Identifies Individuals With Cancer Predisposition Syndromes Missed by Current Screening Guidelines
ORLANDO, Fla. – Among individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for...
Media Registration Open: AACR Annual Meeting 2023, April 14-19
The American Association for Cancer Research (AACR) will host its 114th Annual Meeting from April 14-19, 2023, at the Orange...